Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
154.2 EUR | -1.46% |
|
+0.44% | +10.08% |
07-12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
07-12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
- Stock Market
- Equities
- ABBV Stock
- 4AB Stock
- News AbbVie Inc.